The Library
Browse by Funders
![]() | Up a level |
Number of items: 1.
HER2 TOP2A Meta-Anal Study Group (Including:
). (2011) HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer : a meta-analysis of individual patient data. Lancet Oncology, Vol.12 (No.12). pp. 1134-1142. ISSN 1470-2045

